ID

32113

Descripción

Efficacy Study on Cognitive Functions in Schizophrenic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00761670

Link

https://clinicaltrials.gov/show/NCT00761670

Palabras clave

Versiones (1)
  1. 18/10/18 18/10/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

18 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00761670

Inglés

Eligibility Schizophrenia NCT00761670

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis: dsm-iv schizophrenia (any subtype)
Descripción

Schizophrenia Subtype Any

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0449560
UMLS CUI [1,3]
C1552551
duration of illness: ≥ 5 years
Descripción

Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0872146
concomitant standing or prn medications (except other antipsychotics and those contraindicated in the respective package inserts [amisulpride or risperidone]) are permitted during treatment phase, if they were present at a stable dose for at least 6 weeks prior to the start of initial treatment with study medication
Descripción

Concomitant Agent Dose Stable | Exception Antipsychotic Agents Other | Exception Pharmaceutical Preparations Contraindicated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0040615
UMLS CUI [2,3]
C0205394
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C1444657
overall symptom severity: patients must evidence a total score of 60 or higher on the panss scale
Descripción

Symptom severity Overall PANSS

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1319166
UMLS CUI [1,2]
C1561607
UMLS CUI [1,3]
C4086747
clinical symptoms: a score of 4 (moderate) or greater on any of the 7 items of the panss positive symptom subscale is present
Descripción

Symptoms Clinical | PANSS Symptoms Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0205210
UMLS CUI [2,1]
C4086747
UMLS CUI [2,2]
C1457887
UMLS CUI [2,3]
C1514241
cognitive status (minimum performance level): subject must be able to validly complete the baseline matrics assessment
Descripción

Cognitive status | Cognition Schizophrenia Assessment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0945985
UMLS CUI [2,1]
C0009240
UMLS CUI [2,2]
C0036341
UMLS CUI [2,3]
C1516048
clinical judgment by the investigator that treatments with amisulpride or risperidone are warranted due to suboptimal clinical outcome despite previous treatments
Descripción

Amisulpride | Risperidone

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0103045
UMLS CUI [2]
C0073393
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
past or current intolerance of amisulpride or risperidone side effects that are judged by the investigator to be unsafe, dose-limiting, or likely to result in study discontinuation.
Descripción

Intolerance Amisulpride Side effects | Intolerance Risperidone Side effects

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0231199
UMLS CUI [1,2]
C0103045
UMLS CUI [1,3]
C0879626
UMLS CUI [2,1]
C0231199
UMLS CUI [2,2]
C0073393
UMLS CUI [2,3]
C0879626
any contraindication for amisulpride or risperidone therapy as indicated in the drug description.
Descripción

Medical contraindication Amisulpride | Medical contraindication Risperidone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0103045
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0073393
presence of any unstable or untreated medical disorder.
Descripción

Disease Unstable | Disease Untreated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0332155
any history of seizures or seizure disorder other than febrile seizures of childhood;
Descripción

Seizures | Epilepsy | Exception Febrile seizures of childhood

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036572
UMLS CUI [2]
C0014544
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0009952
history of positive hepatitis b surface antigen.
Descripción

Hepatitis B surface antigen positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149709
any abnormal laboratory test that is judged to be clinically significant by the investigator.
Descripción

Laboratory test result abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438215
a history of significant head injury/trauma, as defined by:
Descripción

Craniocerebral Trauma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018674
a. loss of consciousness (loc) for more than 1 hour b. recurring seizures resulting from the head injury c. clear cognitive sequelae of the injury d. cognitive rehabilitation following the injury
Descripción

Unconscious State Duration | Recurrent seizures Due to Craniocerebral Trauma | Sequelae Cognitive Due to Craniocerebral Trauma | Cognitive rehabilitation Following Craniocerebral Trauma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0041657
UMLS CUI [1,2]
C0449238
UMLS CUI [2,1]
C0748607
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0018674
UMLS CUI [3,1]
C0243088
UMLS CUI [3,2]
C1516691
UMLS CUI [3,3]
C0678226
UMLS CUI [3,4]
C0018674
UMLS CUI [4,1]
C0870303
UMLS CUI [4,2]
C0332282
UMLS CUI [4,3]
C0018674
alcohol or substance dependence within the past 12 months or abuse within the past 3 months. any subject with positive urine toxicology or alcohol use that is considered abnormal at baseline.
Descripción

Substance Dependence | Substance Use Disorders | Urine Toxicology Positive | Alcohol consumption Abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038580
UMLS CUI [2]
C0038586
UMLS CUI [3,1]
C0042036
UMLS CUI [3,2]
C0852616
UMLS CUI [3,3]
C1514241
UMLS CUI [4,1]
C0001948
UMLS CUI [4,2]
C0205161
clinically significant suicidal or homicidal behavior or attempts within past 6 months.
Descripción

Suicidal behavior | Homicidal behavior | Suicide attempt | Homicide attempt

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1760428
UMLS CUI [2]
C1828354
UMLS CUI [3]
C0038663
UMLS CUI [4]
C0277662
pregnant or breast-feeding women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
absence of medically approved contraceptive methods for female of childbearing potential.
Descripción

Childbearing Potential Contraceptive methods Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332197
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Descripción

Study Subject Participation Status | Considerations Additional

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0518609
UMLS CUI [2,2]
C1524062
Volver a la parte superior de la página

Similar models

Eligibility Schizophrenia NCT00761670

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia Subtype Any
Item
diagnosis: dsm-iv schizophrenia (any subtype)
boolean
C0036341 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Disease length
Item
duration of illness: ≥ 5 years
boolean
C0872146 (UMLS CUI [1])
Concomitant Agent Dose Stable | Exception Antipsychotic Agents Other | Exception Pharmaceutical Preparations Contraindicated
Item
concomitant standing or prn medications (except other antipsychotics and those contraindicated in the respective package inserts [amisulpride or risperidone]) are permitted during treatment phase, if they were present at a stable dose for at least 6 weeks prior to the start of initial treatment with study medication
boolean
C2347852 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0040615 (UMLS CUI [2,2])
C0205394 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C1444657 (UMLS CUI [3,3])
Symptom severity Overall PANSS
Item
overall symptom severity: patients must evidence a total score of 60 or higher on the panss scale
boolean
C1319166 (UMLS CUI [1,1])
C1561607 (UMLS CUI [1,2])
C4086747 (UMLS CUI [1,3])
Symptoms Clinical | PANSS Symptoms Positive
Item
clinical symptoms: a score of 4 (moderate) or greater on any of the 7 items of the panss positive symptom subscale is present
boolean
C1457887 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C4086747 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C1514241 (UMLS CUI [2,3])
Cognitive status | Cognition Schizophrenia Assessment
Item
cognitive status (minimum performance level): subject must be able to validly complete the baseline matrics assessment
boolean
C0945985 (UMLS CUI [1])
C0009240 (UMLS CUI [2,1])
C0036341 (UMLS CUI [2,2])
C1516048 (UMLS CUI [2,3])
Amisulpride | Risperidone
Item
clinical judgment by the investigator that treatments with amisulpride or risperidone are warranted due to suboptimal clinical outcome despite previous treatments
boolean
C0103045 (UMLS CUI [1])
C0073393 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Intolerance Amisulpride Side effects | Intolerance Risperidone Side effects
Item
past or current intolerance of amisulpride or risperidone side effects that are judged by the investigator to be unsafe, dose-limiting, or likely to result in study discontinuation.
boolean
C0231199 (UMLS CUI [1,1])
C0103045 (UMLS CUI [1,2])
C0879626 (UMLS CUI [1,3])
C0231199 (UMLS CUI [2,1])
C0073393 (UMLS CUI [2,2])
C0879626 (UMLS CUI [2,3])
Medical contraindication Amisulpride | Medical contraindication Risperidone
Item
any contraindication for amisulpride or risperidone therapy as indicated in the drug description.
boolean
C1301624 (UMLS CUI [1,1])
C0103045 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0073393 (UMLS CUI [2,2])
Disease Unstable | Disease Untreated
Item
presence of any unstable or untreated medical disorder.
boolean
C0012634 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Seizures | Epilepsy | Exception Febrile seizures of childhood
Item
any history of seizures or seizure disorder other than febrile seizures of childhood;
boolean
C0036572 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0009952 (UMLS CUI [3,2])
Hepatitis B surface antigen positive
Item
history of positive hepatitis b surface antigen.
boolean
C0149709 (UMLS CUI [1])
Laboratory test result abnormal
Item
any abnormal laboratory test that is judged to be clinically significant by the investigator.
boolean
C0438215 (UMLS CUI [1])
Craniocerebral Trauma
Item
a history of significant head injury/trauma, as defined by:
boolean
C0018674 (UMLS CUI [1])
Unconscious State Duration | Recurrent seizures Due to Craniocerebral Trauma | Sequelae Cognitive Due to Craniocerebral Trauma | Cognitive rehabilitation Following Craniocerebral Trauma
Item
a. loss of consciousness (loc) for more than 1 hour b. recurring seizures resulting from the head injury c. clear cognitive sequelae of the injury d. cognitive rehabilitation following the injury
boolean
C0041657 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0748607 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0018674 (UMLS CUI [2,3])
C0243088 (UMLS CUI [3,1])
C1516691 (UMLS CUI [3,2])
C0678226 (UMLS CUI [3,3])
C0018674 (UMLS CUI [3,4])
C0870303 (UMLS CUI [4,1])
C0332282 (UMLS CUI [4,2])
C0018674 (UMLS CUI [4,3])
Substance Dependence | Substance Use Disorders | Urine Toxicology Positive | Alcohol consumption Abnormal
Item
alcohol or substance dependence within the past 12 months or abuse within the past 3 months. any subject with positive urine toxicology or alcohol use that is considered abnormal at baseline.
boolean
C0038580 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0042036 (UMLS CUI [3,1])
C0852616 (UMLS CUI [3,2])
C1514241 (UMLS CUI [3,3])
C0001948 (UMLS CUI [4,1])
C0205161 (UMLS CUI [4,2])
Suicidal behavior | Homicidal behavior | Suicide attempt | Homicide attempt
Item
clinically significant suicidal or homicidal behavior or attempts within past 6 months.
boolean
C1760428 (UMLS CUI [1])
C1828354 (UMLS CUI [2])
C0038663 (UMLS CUI [3])
C0277662 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Absent
Item
absence of medically approved contraceptive methods for female of childbearing potential.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Study Subject Participation Status | Considerations Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
C0518609 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial